The role of interleukin-2 in the treatment of cancer patients (eBook, PDF)

Redaktion: Wagstaff, J.

• Format: PDF

Produktbeschreibung

Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer Netherlands
• Seitenzahl: 191
• Erscheinungstermin: 6. Dezember 2012
• Englisch
• ISBN-13: 9789401117531
• Artikelnr.: 44044752

Inhaltsangabe

1. Introduction.- 2. Interleukin-2 as a single agent: dose, scheduling and optimum immunomodulatory dose.- 3. Interleukin-2 and lymphokine activated killer (LAK) cells.- 4. Interleukin-2 toxicity: mechanisms and management.- 5. Interleukin-2: biology and immunology.- 6. Interleukin-2 and tumour eradication by cytotoxic T lymphocytes.- 7. Combination treatment with Interleukin-2 and chemotherapeutic agents.- 8. Interleukin-2, lymphocytes and monoclonal antibodies.- 9. Interleukin-2 and other cytokines.- 10. Future prospects for Interleukin-2 therapy.